开窗/分支动脉瘤修复术后二次干预常见且不损害长期生存
这项多中心研究纳入2005至2020年9项医师发起豁免研究中的1681例开窗/分支腔内腹主动脉瘤修复患者,385例(23%)接受了二次干预,二次干预总体与长期生存改善相关(HR 0.6,95%CI 0.5-0.7),但高幅度和开放手术二次干预与生存下降及动脉瘤相关死亡率升高相关。
要点
- 开窗/分支腔内修复术后23%患者需二次干预,1年免于再干预率82%、5年59%。
- 二次干预多为经皮(84%)、轻微(70%)、低幅度(81%),技术成功率94%,二次干预相关死亡率<1%。
- 高幅度(HR 1.0,95%CI 0.7-1.5)和开放(HR 1.0,95%CI 0.7-1.5)二次干预与生存改善无关。
核心结论
- 开窗/分支腔内腹主动脉瘤修复术后二次干预常见,多为经皮、轻微和低幅度操作。
- 高幅度和开放二次干预虽不常见,但与长期生存下降和动脉瘤相关死亡率升高相关。
- 这些数据强调密切终身监测的重要性,并提示应预期较高的二次干预率,但不会对生存产生负面影响。
研究设计与样本
- 多中心研究联盟中9项独立医师发起豁免研究,2005至2020年连续纳入1681例开窗/分支腔内腹主动脉瘤修复患者。
- 二次干预按血管外科学会报告标准分为开放或经皮、主要或次要,并按生理效应分为高或低幅度。
- 采用Kaplan-Meier和Cox比例风险比(HR)分析评估长期生存。
主要发现
- 1681例中385例(23%)在随访期间需要二次干预,1年免于再干预率82%,5年59%,平均随访23个月。
- 二次干预中经皮占84%、轻微占70%、低幅度占81%;肾动脉支架置入(30%)和入路相关操作(24%)分别是最常见的经皮和开放操作。
- 19%的患者需要高幅度手术;二次干预技术成功率94%,二次干预相关死亡率<1%。
- 二次干预总体与长期生存改善相关(HR 0.6,95%CI 0.5-0.7);主要(HR 0.6,95%CI 0.4-0.8)、次要(HR 0.6,95%CI 0.5-0.8)、低幅度(HR 0.5,95%CI 0.4-0.7)和经皮(HR 0.6,95%CI 0.5-0.7)二次干预均与生存改善相关。
- 高幅度(HR 1.0,95%CI 0.7-1.5)和开放(HR 1.0,95%CI 0.7-1.5)二次干预与生存改善无关;动脉瘤相关生存分析中,低幅度二次干预改善生存(HR 0.3,95%CI 0.1-0.7),高幅度(HR 2.8,95%CI 1.4-5.8)和开放(HR 2.7,95%CI 1.3-5.5)二次干预与死亡率增加相关。
临床怎么用
- 原文结论强调密切终身监测的重要性,并提示应预期较高的二次干预率但不会对生存产生负面影响。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Secondary interventions are common after endovascular repair of aortic aneurysms. However, the frequency and procedural details of secondary interventions after fenestrated or branched endovascular abdominal aortic aneurysm repair (F/BEVAR) have been less well described, and the effects on long-term survival and aneurysm-related mortality are unknown. METHODS: Consecutive patients enrolled as a part of a multicenter research consortium in nine independent physician-sponsored investigational device exemption studies from 2005 to 2020 were evaluated. All secondary interventions performed after the initial procedure were classified as open or percutaneous and as major or minor in accordance with the Society for Vascular Surgery reporting standards. Secondary interventions were further classified as high or low magnitude according to the physiologic effects of the intervention. The demographics, procedural details, and perioperative outcomes were compared between those who had and those who had not undergone secondary interventions. Kaplan-Meier and Cox proportional hazard ratio (HR) analysis were used to evaluate long-term survival. RESULTS: Of 1681 patients who had undergone F/BEVAR, 385 (23%) had required a secondary intervention at any point during follow-up. Freedom from reintervention was 82% at 1 year and 59% at 5 years of follow-up. The mean follow-up period was 23 months. Most secondary interventions were percutaneous (84%), minor (70%), and of low magnitude (81%). Renal stenting (30%) and access-related procedures (24%) were the most frequent percutaneous and open procedures, respectively. High magnitude operations were required for 19% of the patients. Technical success was achieved for 94% of the secondary interventions, and mortality from the secondary interventions was <1%. Secondary interventions as a whole were associated with improved long-term survival (HR, 0.6; 95% confidence interval [CI], 0.5-0.7). In the subgroup analysis, major (HR, 0.6; 95% CI, 0.4-0.8), minor (HR, 0.6; 95% CI, 0.5-0.8), low magnitude (HR, 0.5; 95% CI, 0.4-0.7), and percutaneous (HR, 0.6; 95% CI, 0.5-0.7) secondary interventions were associated with improved survival. However, high magnitude (HR, 1.0; 95% CI, 0.7-1.5) and open (HR, 1.0; 95% CI, 0.7-1.5) secondary interventions were not. Similarly, when aneurysm-related survival was specifically assessed, low magnitude secondary interventions were found to improve survival (HR, 0.3; 95% CI, 0.1-0.7), and high magnitude secondary interventions (HR, 2.8; 95% CI, 1.4-5.8) and open secondary interventions (HR, 2.7; 95% CI, 1.3-5.5) were associated with increased mortality. CONCLUSIONS: Secondary interventions after F/BEVAR were frequent and were typically percutaneous, minor, and low magnitude procedures. Although uncommon, high magnitude and open secondary interventions were associated with decreased long-term survival and increased aneurysm-related mortality. These data highlight the importance of close, lifelong surveillance and suggest that a significant rate of secondary intervention should be anticipated but that these will not negatively affect survival.
引用
- Zettervall SL, Tenorio ER, Schanzer A, et al. Secondary interventions after fenestrated/branched aneurysm repairs are common and nondetrimental to long-term survival. J Vasc Surg. 2021. PMID: 34954272. doi:10.1016/j.jvs.2021.11.074
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。